Antibody Distribution in Colorectal Cancer Treatment
Author Information
Author(s): R.H.J. Begent, J.A. Ledermann, A.J. Green, K.D. Bagshawe, S.J. Riggs, F. Searle, P.A. Keep, T. Adam, R.G. Dale, M.G. Glaser
Primary Institution: Cancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross and Westminster Medical School
Hypothesis
The study investigates the distribution of iodine-131 labelled antibodies in patients with colorectal cancer to optimize therapeutic strategies.
Conclusion
The study found that the distribution of the antibody was more concentrated in tumors compared to normal tissues, suggesting potential for effective therapy.
Supporting Evidence
- The maximum concentrations of the antibody were found in tumors 8 hours after administration.
- Antibody levels were higher in tumors than in any other tissue on average.
- The use of a second antibody improved the tumor to blood ratio.
- Cumulative radiation doses to tumor and normal tissue were estimated.
- Patients with efficient localization had a tumor to body ratio of 20:1.
- Antibody clearance from tissues occurred over one week.
- Variability in antibody uptake was significant among patients.
- Second antibody administration had little effect on other tissues.
Takeaway
Doctors used a special antibody to help treat cancer, and they found that it worked better in the tumors than in other parts of the body.
Methodology
Patients received iodine-131 labelled antibodies, and their distribution was measured using gamma-camera imaging and blood and urine analysis.
Potential Biases
Potential biases may arise from the variability in individual patient responses to the treatment.
Limitations
The study had a small sample size and variability in antibody uptake among patients.
Participant Demographics
Patients had unresectable local recurrent or metastatic carcinoma of the colon or rectum.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website